The South Korea biosensors market size reached USD 588.90 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,078.13 Million by 2033, exhibiting a growth rate (CAGR) of 6.95% during 2025-2033. The rising prevalence of chronic diseases like diabetes, cardiovascular conditions, and respiratory diseases in South Korea is impelling the market growth. Moreover, technological advancement has been the major force in fueling the market growth. Apart from this, the government policies and investments in healthcare technology are expanding the South Korea biosensors market share.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 588.90 Million |
Market Forecast in 2033 | USD 1,078.13 Million |
Market Growth Rate 2025-2033 | 6.95% |
Increasing Occurrence of Chronic Ailments
The rising prevalence of chronic diseases like diabetes, cardiovascular conditions, and respiratory diseases in South Korea is impelling the market growth. The country has witnessed a gradual increase in the number of chronic disease cases, which is mainly attributed to the aging population and lifestyle factors, such as a deteriorating diet and lower levels of physical activity. As a result, the Korean Diabetes Association (KDA) has created the 2025 Diabetes Clinical Practice Guidelines to offer evidence-based advice regarding the diagnosis, screening, prevention, and management of diabetes and its related complications. This is encouraging the usage of efficient technologies to manage diabetes among the masses. Biosensors provide real-time measurement of blood glucose levels, heart rate, and other vital signs to patients, giving them more effective management choices. The need for inexpensive, non-invasive, and effective diagnostic equipment has driven the market for wearable biosensors, particularly those concerning glucose monitoring for diabetic individuals. Furthermore, South Korea's health system prioritizes preventative medicine, which has contributed to the increased use of these devices as well. The need for ongoing health monitoring solutions has spurred the progress of sophisticated biosensors, which will guarantee improved disease control and improve patient outcomes.
To get more information on this market, Request Sample
Biosensor Device Technological Advances in Device
Technological improvements have been the major force in fueling the South Korea biosensors market growth. Development in sensor technology, miniaturization, and the integration of biosensors with smartphones and other digital health platforms have revolutionized the manner in which health monitoring is performed. Materials science advancements, including nanomaterials for enhanced sensitivity and accuracy for detection, have greatly enhanced the performance of biosensors. The growing need for point-of-care (POC) testing and home health monitoring products is also driving the market. Additionally, the confluence of biosensors with artificial intelligence (AI) and machine learning algorithms provides real-time data analytics, further amplifying diagnostic capabilities and patient management. All these have made the use of biosensors more convenient and economical, driving their use not just in clinical environments but among consumers looking for personal health monitoring products as well.
Public Support and Funding for Healthcare Innovation
Government policies and investments in healthcare technology are offering a favorable market outlook. The government of South Korea has made healthcare technology a priority in its national strategy to counter the demographic problem of aging and the growing burden of healthcare. Research and development (R&D) support programs for medical devices, including biosensors, have spurred innovation and commercialization of these devices. Moreover, the administration has offered subsidies and incentives for uptake of advanced medical technologies in public as well as private healthcare. The aid has been effective in creating a conducive climate for the evolution of innovative biosensor solutions, strengthening the market growth. South Korea's active emphasis on technology and innovation and policies to enhance healthcare infrastructure continues to provide opportunities for biosensor manufacturers to establish increased presence within the market.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2025-2033. Our report has categorized the market based on product, technology, application, and end use.
Product Insights:
The report has provided a detailed breakup and analysis of the market based on the product. This includes wearable biosensors and non-wearable biosensors.
Technology Insights:
A detailed breakup and analysis of the market based on the technology have also been provided in the report. This includes electrochemical biosensors, optical biosensors, piezoelectric biosensors, thermal biosensors, nanomechanical biosensors, and others.
Application Insights:
The report has provided a detailed breakup and analysis of the market based on the application. This includes blood glucose testing, cholesterol testing, blood gas analysis, pregnancy testing, drug discovery, infectious disease testing, and others.
End Use Insights:
A detailed breakup and analysis of the market based on the end use have also been provided in the report. This includes point of care testing, home healthcare diagnostics, research laboratories, security and biodefense, and others.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include Seoul Capital Area, Yeongnam (Southeastern Region), Honam (Southwestern Region), Hoseo (Central Region), and others.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Scope of the Report |
Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Products Covered | Wearable Biosensors, Non-Wearable Biosensors |
Technologies Covered | Electrochemical Biosensors, Optical Biosensors, Piezoelectric Biosensors, Thermal Biosensors, Nanomechanical Biosensors, Others |
Applications Covered | Blood Glucose Testing, Cholesterol Testing, Blood Gas Analysis, Pregnancy Testing, Drug Discovery, Infectious Disease Testing, Others |
End Uses Covered | Point of Care Testing, Home Healthcare Diagnostics, Research Laboratories, Security and Biodefense, Others |
Regions Covered | Seoul Capital Area, Yeongnam (Southeastern Region), Honam (Southwestern Region), Hoseo (Central Region), Others |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: